Journal of Cardiobiology

Research Article

Caffeic Acid Phenethyl Ester Mitigates Oxidative Stress and Restores Vascular and Heart Function

Castellano A, Lefkowitz D, Sandhu R, Kim A, Wieczorek P, Kuhn T, Liu S, Kucharski K, Venditto J, Kuo D, Ibe A, Barsotti R, Young LH and Chen Q*

Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, USA
*Address for Correspondence: Chen Q, Department of Bio-Medical Sciences, Philadelphia College of Osteopathic Medicine, USA, Tel: 215-871-6153, Fax: 215-871-6869; E-mail: qianch@pcom.edu
Castellano A and Lefkowitz D shared co-first authorship and contributed equally
Submission: 27 October 2020; Accepted: 29 November, 2020; Published: 15 December, 2020
Copyright: © 2020 Chen Q and Castellano A et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Oxidative stress, such as increased hydrogen peroxide (H2O2) levels, is a major event initiating pathogenesis of various cardiovascular diseases. The effects of Caffeic Acid Phenethyl Ester (CAPE), a natural antioxidant compound, on oxidative stress-induced cardiac cell damage and vascular/heart dysfunction have not been fully elucidated. In this study, the effects of CAPE were tested in H2O2-induced H9c2 cell damage, a hind limb ischemia (I, 30 min)/reperfusion (R, 60 min), and a global heart ischemia (I, 30 min)/reperfusion (R, 60 min) conditions. We found that H2O2 (300 -700 μM; n=8) concentration-dependently decreased H9c2 cell viability accompanied with increased intracellular reactive oxygen species (ROS). H2O2 (500 μM) significantly decreased cell viability to 23 ± 3% with a significantly increased intracellular ROS levels by 2.95 ± 0.6 fold when compared to the control (both p<0.05). By contrast, co-treatment of CAPE (10 to 40 μM) and 500 μM H2O2 (n=5) significantly improved cell viability associated with reduction of intracellular ROS in a concentration-dependent manner (p<0.05). Similarly, CAPE (0.95 mg/Kg, equivalent to 40 μM in blood, n=5) when given at reperfusion significantly reduced blood H2O2 levels during reperfusion compared to saline treatment in a rat hind limb I (30 min)/R (60 min) model (all p<0.05). Last, CAPE (40 μM, n=5) given at beginning of reperfusion for 5 minutes significantly salvage heart tissue and cardiac contractile function when compared to untreated I/R hearts (n=11; all p<0.05) during 60 min. reperfusion. The cardio-protective effects of CAPE were significantly abolished by a non-selective nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester (50 μM, n=5), or a heme oxygenase-1 inhibitor, SnPPIX (20 μM, n=5) (all p<0.05). These results suggest that CAPE mitigates H2O2 caused cardiac cell damage and I/R induced vascular and heart dysfunction possibly by reducing oxidative stress and/or increasing heme oxygenase-1 and nitric oxide synthase activity.